Related Experiment Videos
Successful treatment of empyema thoracis with human recombinant deoxyribonuclease
G Simpson1, D Roomes, B Reeves
1Department of Thoracic Medicine, Cairns Base Hospital, Cairns, Queensland, Australia. marjo@iig.com.au
Thorax
|April 2, 2003
Abstract:
Fibrinolytic enzymes, particularly streptokinase, are now widely used to treat empyema thoracis. Recent in vitro evidence suggests that streptokinase has no effect on pus viscosity but that deoxyribonuclease (DNase) reduces the viscosity of pus. We report the first use of human recombinant DNase given intrapleurally to treat an empyema which had not resolved after standard treatment with streptokinase.